Analysis-Nine months in, Starbucks CEO faces tall order in turnaround

Starbucks (SBUX) is experiencing persistent operational challenges under new CEO Brian Niccol, with global same-store sales declining 1% for the fifth consecutive quarter and average monthly customer visits continuing to fall. Despite Niccol's reputation as a turnaround expert, SBUX shares have stagnated since his appointment, and investors remain skeptical due to the absence of detailed financial targets and an investor day not planned until 2026. This uncertainty, coupled with a high forward P/E of 33.2 and an estimated $1.5B-$2B cost for accelerated staffing initiatives, has led to analyst downgrades and a 'show-me' stance from the market.

Analysis

Despite high expectations following the appointment of renowned turnaround CEO Brian Niccol, Starbucks (SBUX) is exhibiting continued operational weakness and testing investor patience. The company reported a 1% decline in global same-store sales for the quarter ending March 30, marking the fifth consecutive quarterly contraction. This trend is corroborated by third-party data from Placer.ai, which shows a consistent year-over-year decline in average monthly customer visits throughout 2025. Niccol's "Back to Starbucks" strategy, which involves significant investment in staffing estimated at $1.5 to $2 billion over two years, has not yet reversed the negative momentum. Consequently, the stock has stagnated since his appointment, underperforming the S&P 500 by 15%, while trading at a premium forward P/E ratio of 33.2. The primary driver of market skepticism, reflected in analyst downgrades and a shift from 'buy' to 'hold' ratings, is the lack of specific financial targets and the deferral of an investor day until 2026, creating a 'show-me' scenario for the market.

Key Decisions for Investors

• Investors should exercise caution as the market remains in a 'show-me' stage, awaiting tangible evidence that the new strategy can reverse declining sales and customer traffic.
• Monitor upcoming quarterly reports for an inflection in same-store sales and customer visit frequency, as these are the primary metrics that will validate the high cost of the turnaround plan.
• The stock's premium valuation at a 33.2 forward P/E presents a downside risk, particularly given the persistent negative fundamentals and the absence of clear financial guidance from management.
• Consider deferring significant new positions until the company provides a detailed strategic roadmap and financial targets, which are not expected until the 2026 investor day.